Common stock

FRMO Corp. Announces Results for Fiscal 2022 and Virtual Annual Meeting

Retrieved on: 
Friday, August 12, 2022

FRMO Corp. (the Company or FRMO) (OTC Pink: FRMO) today reported its financial results for the fiscal year 2022, ended May 31, 2022.

Key Points: 
  • FRMO Corp. (the Company or FRMO) (OTC Pink: FRMO) today reported its financial results for the fiscal year 2022, ended May 31, 2022.
  • Annual net income (loss) attributable to the Company in the fiscal year ended May 31, 2022 was $2,945,877, or $0.07 per share, compared to $60,158,194, or $1.37 per share, a year earlier.
  • Further details are available in the Companys Consolidated Financial Statements for the fiscal year ended May 31, 2022.
  • Murray Stahl, Chairman and CEO, and Steven Bregman, President and CFO, will host the 2022 Annual Meeting of Shareholders (Meeting) at 3:00 p.m.

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Retrieved on: 
Friday, August 12, 2022

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the grant of inducement awards to seven new employees.

Key Points: 
  • (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the grant of inducement awards to seven new employees.
  • The Compensation Committee of the Board of Directors of Marinus approved the grant of non-qualified stock options to purchase an aggregate of 57,975 shares of its common stock (the Common Stock) as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
  • The stock options were granted as an inducement material to each of the employees entering into employment with Marinus in accordance with Nasdaq Listing Rule 5635(c)(4), and are subject to the terms and conditions of the applicable award agreement covering such grant.
  • Marinus is a commercial-stage pharmaceutical company dedicated to the development of innovative therapeutics for seizure disorders.

Rubicon Technology, Inc. Sets Record Date for its $11.00 per share Cash Distribution

Retrieved on: 
Friday, August 12, 2022

The Distribution and the Record Date are conditioned upon the consummation of the Offer by August 19, 2022.

Key Points: 
  • The Distribution and the Record Date are conditioned upon the consummation of the Offer by August 19, 2022.
  • If such condition has occurred it is anticipated that the Distribution will be paid on or about August 29, 2022 (the Payment Date).
  • The Common Stock will not trade ex-dividend until August 30, 2022, the first business day after the Payment Date.
  • Due bills obligate a seller of Common Stock to deliver the Distribution payable on such Common Stock to the buyer.

Warner Music Group Corp. Announces Quarterly Cash Dividend

Retrieved on: 
Friday, August 12, 2022

NEW YORK, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Warner Music Group Corp. (Warner Music Group or WMG) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.16 per share on WMGs Class A Common Stock and Class B Common Stock, representing an aggregate quarterly dividend of approximately $82.4 million (based on the issued and outstanding shares of Class A Common Stock and Class B Common Stock).

Key Points: 
  • NEW YORK, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Warner Music Group Corp. (Warner Music Group or WMG) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.16 per share on WMGs Class A Common Stock and Class B Common Stock, representing an aggregate quarterly dividend of approximately $82.4 million (based on the issued and outstanding shares of Class A Common Stock and Class B Common Stock).
  • More information about Warner Music Group and other risks related to Warner Music Group are detailed in Warner Music Groups most recent annual report on Form 10-K and its quarterly reports on Form 10-Q and current reports on Form 8-K as filed with the Securities and Exchange Commission.
  • Financial and other material information regarding Warner Music Group is routinely posted on and accessible at http://investors.wmg.com .
  • Additional factors that may affect future results and conditions are described in Warner Music Groups filings with the SEC, which are available at the SECs web site at www.sec.gov or at Warner Music Groups website at www.wmg.com .

NextMart, Inc. - Acquisition of Black Widow Permian Energy, LLC

Retrieved on: 
Friday, August 12, 2022

CARLSBAD, N.M., Aug. 12, 2022 /PRNewswire/ -- NextMart, Inc. (the "Company" or "NXMR" - Pink Sheets Alternative Reporting Pink: NXMR) NXMR would like to announce it completed the acquisition of Black Widow Permian Energy, Limited Liability Company, that provides oil field services in the Permian Basin ("Black Widow").

Key Points: 
  • CARLSBAD, N.M., Aug. 12, 2022 /PRNewswire/ -- NextMart, Inc. (the "Company" or "NXMR" - Pink Sheets Alternative Reporting Pink: NXMR) NXMR would like to announce it completed the acquisition of Black Widow Permian Energy, Limited Liability Company, that provides oil field services in the Permian Basin ("Black Widow").
  • Black Widow has approximately $1.5 USD in top line revenue since its inception in 2020.
  • It is expected that Black Widow is on pace to record top line revenue of $1.5M USD in fiscal year 2020.
  • The Company has now acquired three oil field services operations located in the Permian Basin with the current acquisition of Black Widow.

Vigil Neuroscience Announces $75 Million Private Placement Financing

Retrieved on: 
Friday, August 12, 2022

Vigil anticipates the gross proceeds from the PIPE to be approximately $75.0 million, before deducting fees to the placement agent and other offering expenses payable by the Company.

Key Points: 
  • Vigil anticipates the gross proceeds from the PIPE to be approximately $75.0 million, before deducting fees to the placement agent and other offering expenses payable by the Company.
  • The closing of the financing is expected to occur on August 16, 2022, subject to customary closing conditions.
  • We thank our existing and new investors who have shown their support for and confidence in Vigil through this financing, said Ivana Magovevi-Liebisch, Ph.D., J.D., President and Chief Executive Officer of Vigil.
  • Jefferies acted as exclusive placement agent in the private placement.

Amneal launches 4 new Generic products, including Vasopressin single-dose

Retrieved on: 
Thursday, August 11, 2022

Each year, we target 20 to 30 new product launches in generics, and we are on-track to achieving that goal again in 2022.

Key Points: 
  • Each year, we target 20 to 30 new product launches in generics, and we are on-track to achieving that goal again in 2022.
  • Vasopressin injection 1mL is a generic version of the antidiuretic hormone Vasostrict.
  • Famotidine for oral suspension (40 mg/5 mL), an H2 antagonist, is a generic equivalent for Pepcid.
  • This product received Competitive Generic Therapy (CGT) approval designation as Amneal continues to have the highest number of CGT designated products in the industry.

Exchange Listing, LLC Advises Treasure Global Inc. and Secures Initial Public Offering and Nasdaq Listing

Retrieved on: 
Thursday, August 11, 2022

New York, NY, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Exchange Listing, LLC has nalized the Nasdaq Capital Markets listing for its client, Treasure Global Inc ("TGI" or the "Company") (Nasdaq: TGL) on August 10, 2022.

Key Points: 
  • New York, NY, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Exchange Listing, LLC has nalized the Nasdaq Capital Markets listing for its client, Treasure Global Inc ("TGI" or the "Company") (Nasdaq: TGL) on August 10, 2022.
  • Concurrent with the Nasdaq listing, the Company announced the pricing of its initial public offering of 2,000,000 shares of common stock (the "Common Stock") at a public offering price of $4.00 per share.
  • In addition, the Exchange Listing team was hyper-focused on the successful outcome of securing necessary growth capital and the Nasdaq listing".
  • Exchange Listing serves as the primary point of contact with the exchange, investment bankers, and lawyers throughout the listing process.

Chicken Soup for the Soul Entertainment Completes Acquisition of Redbox Entertainment Inc.

Retrieved on: 
Thursday, August 11, 2022

Chicken Soup for the Soul Entertainment (NASDAQ: CSSE) today announced the company has completed the acquisition of Redbox Entertainment Inc. (NASDAQ: RDBX) creating an entertainment content and distribution offering targeting value-conscious consumers.

Key Points: 
  • Chicken Soup for the Soul Entertainment (NASDAQ: CSSE) today announced the company has completed the acquisition of Redbox Entertainment Inc. (NASDAQ: RDBX) creating an entertainment content and distribution offering targeting value-conscious consumers.
  • Ive been looking forward to the day Redbox would become part of the Chicken Soup for the Soul Entertainment family and today is that day.
  • Chicken Soup for the Soul Entertainment is a subsidiary of Chicken Soup for the Soul, LLC, which publishes the famous book series and produces super-premium pet food under the Chicken Soup for the Soul brand name.
  • This communication relates to the business combination transaction between Chicken Soup for the Soul Entertainment, Inc. (CSSE) and Redbox Entertainment Inc. (RDBX).

Broadstone Net Lease, Inc. Announces Pricing of Public Offering of Common Stock

Retrieved on: 
Thursday, August 11, 2022

Broadstone Net Lease, Inc. (NYSE: BNL), (BNL), today announced the pricing of an underwritten public offering of 13,000,000 shares of its Common Stock, at a price to the public of $21.35 per share, less underwriting discounts and commissions, in connection with the forward sale agreements described below.

Key Points: 
  • Broadstone Net Lease, Inc. (NYSE: BNL), (BNL), today announced the pricing of an underwritten public offering of 13,000,000 shares of its Common Stock, at a price to the public of $21.35 per share, less underwriting discounts and commissions, in connection with the forward sale agreements described below.
  • The underwriters also have been granted a 30-day option to purchase up to an additional 1,950,000 shares of Common Stock at the public offering price, less underwriting discounts and commissions.
  • Goldman Sachs & Co. LLC, BMO Capital Markets, J.P. Morgan, and Truist Securities are acting as joint book-running managers of the offering.
  • BNL will not initially receive any proceeds from the sale of shares of Common Stock by the forward purchasers and their affiliates in the offering.